Strategies to meet the need for long-term data

作者: John Chalmers , Mark Woodward , Claudio Borghi , Athanasios Manolis , Giuseppe Mancia

DOI: 10.1097/HJH.0000000000000987

关键词:

摘要: Chronic diseases afflict patients for many years, often to the end of life, and there is increasing need estimating lifelong risk evaluating effects treatment in long term. Yet recommendations are most frequently based on findings from randomized clinical trials lasting only a few years. There therefore clear much longer term data, here we present advantages disadvantages strategies, including use long-term posttrial follow-up, prospective cohort studies, registry databases, administrative databases. We also emphasize cost-effectiveness studies. One promising strategies comes linkage data gathered through ever-expanding pool databases worldwide with other sources, forms observational study.

参考文章(46)
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. The New England Journal of Medicine. ,vol. 358, pp. 2560- 2572 ,(2008) , 10.1056/NEJMOA0802987
Sallie-Anne Pearson, Nicole Pesa, Julia M. Langton, Annabelle Drew, Margaret Faedo, Jane Robertson, Studies using Australia's Pharmaceutical Benefits Scheme data for pharmacoepidemiological research: a systematic review of the published literature (1987-2013). Pharmacoepidemiology and Drug Safety. ,vol. 24, pp. 447- 455 ,(2015) , 10.1002/PDS.3756
Diabetes Control and Complications Trial, None, Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. The New England Journal of Medicine. ,vol. 353, pp. 2643- 2653 ,(2005) , 10.1056/NEJMOA052187
Michael A. Weber, Ernesto L. Schiffrin, William B. White, Samuel Mann, Lars H. Lindholm, John G. Kenerson, John M. Flack, Barry L. Carter, Barry J. Materson, C. Venkata S. Ram, Debbie L. Cohen, Jean-Claude Cadet, Roger R. Jean-Charles, Sandra Taler, David Kountz, Raymond Townsend, John Chalmers, Agustin J. Ramirez, George L. Bakris, Jiguang Wang, Aletta E. Schutte, John D. Bisognano, Rhian M. Touyz, Dominic Sica, Stephen B. Harrap, Clinical practice guidelines for the management of hypertension in the community a statement by the american society of hypertension and the international society of hypertension Journal of Hypertension. ,vol. 32, pp. 3- 15 ,(2014) , 10.1097/HJH.0000000000000065
A Parodi, F Nicotra, A Zambon, L Merlino, G Cesana, G Mancia, G Corrao, Better compliance to antihypertensive medications reduces cardiovascular risk. Journal of Hypertension. ,vol. 29, pp. 610- 618 ,(2011) , 10.1097/HJH.0B013E328342CA97
Ian Ford, Heather Murray, Chris J Packard, James Shepherd, Peter W Macfarlane, Stuart M Cobbe, None, Long-Term Follow-up of the West of Scotland Coronary Prevention Study The New England Journal of Medicine. ,vol. 357, pp. 1477- 1486 ,(2007) , 10.1056/NEJMOA065994
Elizabeth Williamson, Ruth Morley, Alan Lucas, James Carpenter, Propensity scores: From naïve enthusiasm to intuitive understanding Statistical Methods in Medical Research. ,vol. 21, pp. 273- 293 ,(2012) , 10.1177/0962280210394483
N. Beckett, R. Peters, J. Tuomilehto, C. Swift, P. Sever, J. Potter, T. McCormack, F. Forette, B. Gil-Extremera, D. Dumitrascu, J. A. Staessen, L. Thijs, A. Fletcher, C. Bulpitt, , Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to Hypertension in the Very Elderly randomised controlled trial BMJ. ,vol. 344, pp. 111- 111 ,(2011) , 10.1136/BMJ.D7541